Description
CoviRisk TBNK is an advanced blood test that uses flow cytometry to analyze specific immune cell populations in patients with COVID-19. The test focuses on T cells, B cells, and Natural Killer (NK) cells, which are crucial components of the immune response to viral infections. By examining the balance and activation state of these cells, the test can provide insights into the patient’s immune status and potential disease trajectory. This information can be valuable for predicting disease severity, assessing the risk of complications, and guiding treatment decisions in COVID-19 patients.
Reviews
There are no reviews yet.